CureVac N.V.
CVAC · NASDAQ
11/24/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,037,451 | $576,330 | $738,776 |
| - Cash | – | $392,703 | $438,331 | $481,748 |
| + Debt | – | $36,032 | $37,380 | $38,965 |
| Enterprise Value | – | $680,780 | $175,379 | $295,993 |
| Revenue | $493,902 | $1,245 | $893 | $14,469 |
| % Growth | 39,570.8% | 39.4% | -93.8% | – |
| Gross Profit | $472,971 | -$968 | $18 | $12,983 |
| % Margin | 95.8% | -77.8% | 2% | 89.7% |
| EBITDA | $0 | -$54,993 | -$46,745 | -$34,893 |
| % Margin | 0% | -4,417.1% | -5,234.6% | -241.2% |
| Net Income | $338,043 | -$59,560 | -$52,084 | -$32,761 |
| % Margin | 68.4% | -4,783.9% | -5,832.5% | -226.4% |
| EPS Diluted | 1.5 | -0.26 | -0.23 | -0.15 |
| % Growth | 676.9% | -13% | -53.3% | – |
| Operating Cash Flow | – | -$42,062 | -$41,374 | -$66,562 |
| Capital Expenditures | – | -$1,555 | -$511 | -$2,570 |
| Free Cash Flow | – | -$43,617 | -$41,885 | -$69,132 |